U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 32

1.
Ruxolitinib Plus Decitabine Effectively Treats Myelodysplastic Syndrome/Myeloproliferative Neoplasm, Unclassifiable, by Decreasing the Variant Allele Frequency of KRAS
Shuna Luo, Xiaofei Xu, Xingnong Ye, Xiaoqiong Zhu, Cai Wu, Dan Chen, Jingxia Jin, Yan Zheng, Mengli Zheng, Jian Huang
Onco Targets Ther. 2020; 13: 10143–10148. Published online 2020 Oct 9. doi: 10.2147/OTT.S272207
PMCID:
PMC7553600
AbstractArticlePDF–1.6M
2.
Recurrent bilateral adrenal infarction with myelodysplastic/myeloproliferative neoplasm-unclassifiable (MDS/MPN-U): a case report
Yoshitomo Hoshino, Katsunori Manaka, Junichiro Sato, Yui Asatsuma, Hirofumi Horikoshi, Maki Takeuchi, Nobuaki Ito, Megumi Fujita, Megumi Yasunaga, Kensuke Matsuda, Akira Honda, Hiroaki Maki, Yosuke Masamoto, Mineo Kurokawa, Masaomi Nangaku, Noriko Makita
BMC Endocr Disord. 2023; 23: 128. Published online 2023 Jun 5. doi: 10.1186/s12902-023-01384-5
PMCID:
PMC10240100
AbstractArticlePDF–1.4M
3.
Efficacy of ruxolitinib in a patient with myelodysplastic/myeloproliferative neoplasm unclassifiable and co-mutated JAK2, SF3B1 and TP53
Qian Wang, Hai-ping Dai, Dan-dan Liu, Jun-dan Xie, Hong Yao, Zi-xuan Ding, Ting-ting Tao, Su-ning Chen, Ri Zhang
Leuk Res Rep. 2020; 14: 100229. Published online 2020 Oct 30. doi: 10.1016/j.lrr.2020.100229
PMCID:
PMC7645062
AbstractArticlePDF–2.8M
4.
JAK2 V617F mutation in myelodysplastic syndrome, myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable, refractory anemia with ring sideroblasts with thrombocytosis, and acute myeloid leukemia
Dong Wook Jekarl, Sang Bong Han, Myungshin Kim, Jihyang Lim, Eun-Jee Oh, Yonggoo Kim, Hee-Je Kim, Woo-Sung Min, Kyungja Han
Korean J Hematol. 2010 Mar; 45(1): 46–50. Published online 2010 Mar 31. doi: 10.5045/kjh.2010.45.1.46
PMCID:
PMC2983014
AbstractArticlePDF–328K
5.
Development of a myelodysplastic/myeloproliferative neoplasm-unclassifiable in a patient with acute myeloid leukemia: a case report and literature review
Meifang Zhao, Jingnan Sun, Shanshan Liu, Hongqiong Fan, Yu Fu, Yehui Tan, Sujun Gao
J Int Med Res. 2021 May; 49(5): 03000605211018426. Published online 2021 May 31. doi: 10.1177/03000605211018426
PMCID:
PMC8753788
AbstractArticlePDF–590K
6.
Context Matters: Distinct Disease Outcomes as a Result of Crebbp Hemizygosity in Different Mouse Bone Marrow Compartments
Ting Zhou, Stephanie N. Perez, Ziming Cheng, Marsha C. Kinney, Madeleine E. Lemieux, Linda M. Scott, Vivienne I. Rebel
PLoS One. 2016; 11(7): e0158649. Published online 2016 Jul 18. doi: 10.1371/journal.pone.0158649
PMCID:
PMC4948888
AbstractArticlePDF–4.7M
7.
MDS/MPN-Unclassifiable with t(X;17)(q28;q21) and KANSL1-MTCP1/CMC4 Fusion Gene
Peter Molony, Adam C. Smith, Shamini Selvarajah, Ali Sakhdari
Cytogenet Genome Res. 2022 Feb; 161(12): 564–568. Published online 2022 Jan 17. doi: 10.1159/000521509
PMCID:
PMC8988093
AbstractArticle
8.
Prognostic Value of Pretreatment Fetal Hemoglobin Levels in Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia Treated with Azacitidine: A Single-center Retrospective Study
Tomoyuki Saga, Michiyo Kanagawa, Tomoya Harada, Lang Lang, Fumihiko Yamawaki, Toshimichi Ishihara
Intern Med. 2024 Mar 15; 63(6): 781–790. Published online 2023 Jul 26. doi: 10.2169/internalmedicine.1216-22
PMCID:
PMC11008988
AbstractArticlePDF–608K
9.
Adrenal infarction with latent myelodysplastic/myeloproliferative neoplasm, unclassifiable with JAK2V617F mutation
Shunichiro Yasuda, Momoko Chiba, Rie Nishitani, Takako Watanabe
Clin Case Rep. 2024 Apr; 12(4): e8729. Published online 2024 Apr 9. doi: 10.1002/ccr3.8729
PMCID:
PMC11004262
AbstractArticlePDF–970K
10.
Salvage Transplantation with Cord Blood for Graft Rejection of Peripheral Blood Stem Cells due to Donor Specific Antibody
Maria Regina Pelobello de Leon, Shuichiro Takahashi, Masahiro Onozawa, Makoto Ito, Manabu Nakano, Hajime Senjo, Masahiro Chiba, Hiroyuki Ohigashi, Emi Yokoyama, Junichi Sugita, Daigo Hashimoto, Takanori Teshima
Blood Cell Ther. 2020 Nov 25; 3(4): 74–77. Published online 2020 Aug 31. doi: 10.31547/bct-2020-004
PMCID:
PMC9847262
AbstractArticlePDF–227K
11.
Therapy-related myeloid neoplasms following treatment with radioiodine
Thomas Schroeder, Andrea Kuendgen, Sabine Kayser, Nicolaus Kröger, Friederike Braulke, Uwe Platzbecker, Viola Klärner, Fabian Zohren, Detlef Haase, Michael Stadler, Richard Schlenk, Akos G. Czibere, Ingmar Bruns, Roland Fenk, Norbert Gattermann, Rainer Haas, Guido Kobbe, Ulrich Germing
Haematologica. 2012 Feb; 97(2): 206–212. doi: 10.3324/haematol.2011.049114
PMCID:
PMC3269479
AbstractArticlePDF–394K
12.
Hypereosinophilic Syndrome and Clonal Eosinophilia: Point-of-Care Diagnostic Algorithm and Treatment Update
Ayalew Tefferi, Jason Gotlib, Animesh Pardanani
Mayo Clin Proc. 2010 Feb; 85(2): 158–164. doi: 10.4065/mcp.2009.0503
PMCID:
PMC2813824
AbstractArticlePDF–803K
13.
Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia
Nicholas C. P. Cross, Yvette Hoade, William J. Tapper, Gonzalo Carreno-Tarragona, Tiziana Fanelli, Mohamad Jawhar, Nicole Naumann, Iwo Pieniak, Johannes Lübke, Sahra Ali, Kaljit Bhuller, Sonja Burgstaller, Catherine Cargo, Jamie Cavenagh, Andrew S. Duncombe, Emma Das-Gupta, Paul Evans, Peter Forsyth, Philip George, Charlotte Grimley, Fergus Jack, Laura Munro, Varun Mehra, Kavita Patel, Ali Rismani, Gabriela Sciuccati, Rowena Thomas-Dewing, Patrick Thornton, Andres Virchis, Simon Watt, Louise Wallis, Alastair Whiteway, Kris Zegocki, Barbara J. Bain, Andreas Reiter, Andrew Chase
Leukemia. 2019; 33(2): 415–425. Published online 2018 Dec 20. doi: 10.1038/s41375-018-0342-3
PMCID:
PMC6365490
AbstractArticlePDF–1.5M
14.
Timing of the loss of Pten protein determines disease severity in a mouse model of myeloid malignancy
Y. Lucy Liu, Yan Yan, Cody Webster, Lijian Shao, Shelly Y. Lensing, Hongyu Ni, Wei Feng, Natalia Colorado, Rupak Pathak, Zhifu Xiang, Martin Hauer-Jensen, Shaoguang Li, Daohong Zhou, Peter D. Emanuel
Blood. 2016 Apr 14; 127(15): 1912–1922. Prepublished online 2016 Jan 13. doi: 10.1182/blood-2015-05-646216
PMCID:
PMC4832508
AbstractArticle
15.
Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms
Sa A. Wang, Robert P. Hasserjian, Patricia S. Fox, Heesun J. Rogers, Julia T. Geyer, Devon Chabot-Richards, Elizabeth Weinzierl, Joseph Hatem, Jesse Jaso, Rashmi Kanagal-Shamanna, Francesco C. Stingo, Keyur P. Patel, Meenakshi Mehrotra, Carlos Bueso-Ramos, Ken H. Young, Courtney D. Dinardo, Srdan Verstovsek, Ramon V. Tiu, Adam Bagg, Eric D. Hsi, Daniel A. Arber, Kathryn Foucar, Raja Luthra, Attilio Orazi
Blood. 2014 Apr 24; 123(17): 2645–2651. Prepublished online 2014 Mar 13. doi: 10.1182/blood-2014-02-553800
PMCID:
PMC4067498
AbstractArticle
16.
Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge
H-P Horny, K Sotlar, W R Sperr, P Valent
J Clin Pathol. 2004 Jun; 57(6): 604–608. doi: 10.1136/jcp.2003.014860
PMCID:
PMC1770310
AbstractArticlePDF–218K
17.
250K SNP array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies
Andrew J. Dunbar, Lukasz P. Gondek, Christine L. O’Keefe, Hideki Makishima, Manjot S. Rataul, Hadrian Szpurka, Mikkael A. Sekeres, Xiao Fei Wang, Michael A. McDevitt, Jaroslaw P. Maciejewski
Cancer Res. Author manuscript; available in PMC 2009 Dec 15.
Published in final edited form as: Cancer Res. 2008 Dec 15; 68(24): 10349–10357. doi: 10.1158/0008-5472.CAN-08-2754
PMCID:
PMC2668538
AbstractArticlePDF–2.8M
18.
The diagnosis of BCR/ABL-negative chronic myeloproliferative diseases (CMPD): a comprehensive approach based on morphology, cytogenetics, and molecular markers
Torsten Haferlach, Ulrike Bacher, Wolfgang Kern, Susanne Schnittger, Claudia Haferlach
Ann Hematol. 2008 Jan; 87(1): 1–10. Published online 2007 Oct 16. doi: 10.1007/s00277-007-0403-6
PMCID:
PMC2082654
AbstractArticlePDF–218K
19.
Detection of the Activating JAK2 V617F Mutation in Paraffin-Embedded Trephine Bone Marrow Biopsies of Patients with Chronic Myeloproliferative Diseases
Thomas Horn, Marcus Kremer, Tobias Dechow, Walther M. Pfeifer, Birgit Geist, Michael Perker, Justus Duyster, Leticia Quintanilla-Martinez, Falko Fend
J Mol Diagn. 2006 Jul; 8(3): 299–304. doi: 10.2353/jmoldx.2006.050128
PMCID:
PMC1867602
AbstractArticlePDF–289K
20.
Molecular taxonomy of myelodysplastic syndromes and its clinical implications
Elsa Bernard, Robert P. Hasserjian, Peter L. Greenberg, Juan E. Arango Ossa, Maria Creignou, Heinz Tuechler, Jesus Gutierrez-Abril, Dylan Domenico, Juan S. Medina-Martinez, Max Levine, Konstantinos Liosis, Noushin Farnoud, Maria Sirenko, Martin Jädersten, Ulrich Germing, Guillermo Sanz, Arjan A. van de Loosdrecht, Yasuhito Nannya, Olivier Kosmider, Matilde Y. Follo, Felicitas Thol, Lurdes Zamora, Ronald F. Pinheiro, Andrea Pellagatti, Harold K. Elias, Detlef Haase, Christina Ganster, Lionel Ades, Magnus Tobiasson, Laura Palomo, Matteo Giovanni Della Porta, Pierre Fenaux, Monika Belickova, Michael R. Savona, Virginia M. Klimek, Fabio P. S. Santos, Jacqueline Boultwood, Ioannis Kotsianidis, Valeria Santini, Francesc Solé, Uwe Platzbecker, Michael Heuser, Peter Valent, Carlo Finelli, Maria Teresa Voso, Lee-Yung Shih, Michaela Fontenay, Joop H. Jansen, José Cervera, Norbert Gattermann, Benjamin L. Ebert, Rafael Bejar, Luca Malcovati, Seishi Ogawa, Mario Cazzola, Eva Hellström-Lindberg, Elli Papaemmanuil
Blood. 2024 Oct 10; 144(15): 1617–1632. Published online 2024 Jul 6. doi: 10.1182/blood.2023023727
PMCID:
PMC11487646
AbstractArticle

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center